OBJECTIVEHuman autosomal dominant polycystic kidney disease (ADPKD) is characterized by numerous bilateral renal cysts that lead to a decline in kidney function over time. Previous studies reported aquaporin‐3 (AQP3) expression in cysts derived from collecting ducts in ADPKD. The aim of this study is to study the effect of AQP3 on ADPKD development.METHODSAQP3 deficient PKD mice and inducible PKD mice were established in this study. Effect of AQP3 on PKD development was studied with pathological and molecular biological techniques.RESULTSIn both models, kidney size and cyst number were ~30% smaller in AQP3 null PKD mice than in AQP3‐expressing PKD mice, with the difference due mainly to smaller collecting ducts cysts. In matrix cultured MDCK cyst model, AQP3 transfection promoted cyst enlargement. To investigate the mechanism of AQP3‐dependent cyst development, we detected related signaling pathways. It was found that the AMPK/ERK/mTOR signaling, as well as intracellular ATP, were down‐regulated after AQP3 deletion. In addition, overexpression of AQP3 increased intracellular ATP synthesis, and HIF1α and glucose transporter 1 expression.CONCLUSIONWe conclude that AQP3 depletion retards cyst growth, primarily due to AQP3‐dependent energy metabolism. These findings identified the AQP3 as a potential therapeutic target for treating ADPKD.Support or Funding InformationThis work was supported by National Natural Science Foundation of China grants 31200869, 81261160507, 81330074 and 81170632, and the 111 Project.
Read full abstract